Italy vs Japan: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Italy
- Japan
How they compare
Italy currently reports 450 Cases against 332 Cases in Japan, a difference of 118 Cases.
That makes Italy's figure about 1.4 times Japan's.
Across all 40 years both countries report, Italy has been ahead every year.
Italy ranks 10th and Japan ranks 11th of 34 countries.
Italy has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Italy | Japan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 1,189 Cases | 12 Cases | 1,177 Cases | Italy |
| 1990s | 4,021 Cases | 152.7 Cases | 3,868 Cases | Italy |
| 2000s | 1,585 Cases | 374.3 Cases | 1,211 Cases | Italy |
| 2010s | 921.7 Cases | 431.6 Cases | 490.1 Cases | Italy |
| 2020s | 480.8 Cases | 307 Cases | 173.8 Cases | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Italy or Japan?
- Italy, at 450 Cases against 332 Cases in Japan as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Italy and Japan?
- 118 Cases, with Italy ahead.
- How many years of comparable data are there for Italy and Japan?
- 40 years are reported by both, from 1985 to 2024.
- How do Italy and Japan rank globally for communicable diseases — communicable disease incidence?
- Italy ranks 10th and Japan ranks 11th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.